← Leaderboards
Stella Pappa
Emory University
$433,989
Attributed
$433,989
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $208.3K · FY2005–09$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$433,989 · 11
By mechanism
P51$433,989 · 11
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Thomas N. Wichmann$21,015,970
- Yoland Smith$26,141,764
- Stella M Papa$8,841,731
- Adriana Galvan$9,923,837
- Dieter Jaeger$14,318,575
Others in their field
Top investigators on “Source”
- Richard A Gibbs · Baylor College Of Medicine$285,393,445
- David Heimbrook · Leidos Biomedical Research, Inc.$233,184,481
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Jeffrey P Krischer · University Of South Florida$224,745,020
- Albert Lazzarini · California Institute Of Technology$202,317,285
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$155,571,437
Research focus
SourceResearch PersonnelInstitutionResourcesUnited States National Institutes Of HealthFundingParkinson DiseaseComputer Retrieval Of Information On Scientific Projects DatabaseGrantMotorSymptomsPrimatesParkinsonian DisordersCorpus Striatum StructureBehaviorBasal GangliaNeuronsLevodopaLeadPatternDyskinetic SyndromeNovel TherapeuticsDopamineRegulation
Grant awards (11)
REGULATION OF MOTOR FUNCTION IN PARKINSON'S DISEASE$54,800
P51 · FY2009 · RR · contact PI
NMDA-R2B ANTAGONISTS FOR THE THERAPY OF PARKINSON?S DISEASE$54,800
P51 · FY2009 · RR · contact PI
MOTOR EFFECTS OF PDE10A INHIBITORS IN PRIMATES$54,800
P51 · FY2009 · RR · contact PI
NMDA RECEPTOR AS THERAPEUTIC TARGET FOR PARKINSON?S DISEASE$43,907
P51 · FY2009 · RR · contact PI
REGULATION OF MOTOR FUNCTION IN PARKINSON'S DISEASE$35,600
P51 · FY2008 · RR · contact PI
EFFECTS OF CE IN THE MPTP PRIMATE MODEL OF PARKINSON'S DISEASE$39,497
P51 · FY2007 · RR · contact PI
REGULATION OF MOTOR FUNCTION IN PARKINSON'S DISEASE$39,497
P51 · FY2007 · RR · contact PI
EFFECTS OF CE IN THE MPTP PRIMATE MODEL OF PARKINSON'S DISEASE$40,116
P51 · FY2006 · RR · contact PI
REGULATION OF MOTOR FUNCTION IN PARKINSON'S DISEASE$40,116
P51 · FY2006 · RR · contact PI
REGULATION OF MOTOR FUNCTION IN PARKINSON'S DISEASE$15,428
P51 · FY2005 · RR
EFFECTS OF CE IN THE MPTP PRIMATE MODEL OF PARKINSON'S DISEASE$15,428
P51 · FY2005 · RR